Publications

CME/CNE | Preventing Injection-Associated Infections (NYC Health Dept)

The City Health Information (CHI) publication is an evidence-based clinical bulletin for health care providers throughout New York City. The “Preventing Injection-associated Infections in Outpatient Settings” CHI was written to improve patient safety by highlighting unsafe injection practices that increase the risk of infections. The CHI will cover epidemiology of injection-associated infections in the city, … Continue reading CME/CNE | Preventing Injection-Associated Infections (NYC Health Dept)

Article | Results from a Geographically Focused, Community-Based Hep C Screening, Linkage-to-Care & Patient Navigation Program

Journal of General Internal Medicine, July 2015 Many of the five million Americans chronically infected with hepatitis C (HCV) are unaware of their infection and are not in care. OBJECTIVE: We implemented and evaluated HCV screening and linkage-to-care interventions in a community setting. DESIGN: We developed a comprehensive, community-based HCV screening and linkage-to-care program in … Continue reading Article | Results from a Geographically Focused, Community-Based Hep C Screening, Linkage-to-Care & Patient Navigation Program

Article | Excluding People Who Use Drugs or Alcohol from Access to Hep C Treatment – Is This Fair, Given the Available Data?

Journal of Hepatology, August 2015 Revolutionary new drugs to cure hepatitis C virus (HCV) infection represent one of the most important breakthroughs in clinical medicine in recent decades. However, high pricing of these well-tolerated, highly efficacious all-oral regimens and high demand (actual or anticipated) has led many payers in the United States and other countries … Continue reading Article | Excluding People Who Use Drugs or Alcohol from Access to Hep C Treatment – Is This Fair, Given the Available Data?

Article | Recommendations for Management of Hep C among People Who Inject Drugs (International Journal of Drug Policy, 2015)

View in PubMed | View full article in PDF In high income countries, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). In many low and middle income countries large HCV epidemics have also emerged among PWID populations. The burden of HCV-related liver disease among PWID is increasing, but … Continue reading Article | Recommendations for Management of Hep C among People Who Inject Drugs (International Journal of Drug Policy, 2015)

Article | Hep C treatment turned me around: Psychological & Behavioral Transformation Related to Hep C Treatment

“Hepatitis C treatment turned me around:” Psychological and behavioral transformation related to hepatitis C treatment. Drug and Alcohol Dependence, 2015.  Abstract BACKGROUND: Hepatitis C (HCV) is a significant public health problem that primarily affects current and former substance users. However, individuals with a history of substance use are less likely to have access to or … Continue reading Article | Hep C treatment turned me around: Psychological & Behavioral Transformation Related to Hep C Treatment

2015 HIV, HCV & TB Pipeline Report (Treatment Action Group)

DRUGS, DIAGNOSTICS, VACCINES, PREVENTIVE TECHNOLOGIES, RESEARCH TOWARD A CURE, & IMMUNE-BASED & GENE THERAPIES IN DEVELOPMENT JULY 17, 2015 WWW.PIPELINEREPORT.ORG Download PDFs Read online In this year’s report: Dedications The Antiretroviral Pipeline Fit for Purpose: Treatment Optimization The Pediatric Antiretroviral Pipeline Preventive Technologies: Antiretroviral and Vaccine Development Research Toward a Cure and Immune-Based and Gene … Continue reading 2015 HIV, HCV & TB Pipeline Report (Treatment Action Group)

NYC Health Dept Hep B & C Annual Report of Activities (2013)

Overview of Viral Hepatitis Surveillance, Prevention and Control activities at the NYC Department of Health and Mental Hygiene in 2013: Hep B and C Activities Report (pdf) The New York City Department of Health and Mental Hygiene has been actively engaged in hepatitis surveillance, prevention and control for over a decade; however, 2013 marked a year of … Continue reading NYC Health Dept Hep B & C Annual Report of Activities (2013)

Report | Hep B Birth Dose Coverage by NYC Facility (NYC Dept of Health, 2015)

Hepatitis B Birth Dose Coverage by NYC Facility, 2013 Hepatitis B Birth Dose Coverage by NYC Facility, 2012 Percent of infants who received hepatitis B vaccine within 3 days of birth by delivery facility, NYC. Published by the NYC Health Department, 2015. More info here. Hep Free NYC supports the Immunization Action Coalition’s National Hep … Continue reading Report | Hep B Birth Dose Coverage by NYC Facility (NYC Dept of Health, 2015)

Article | Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010). Journal of Sexually Transmitted Diseases, 2015

Journal of Sexually Transmitted Diseases, 2015 See full article:  Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010) (pdf) Background: Hepatitis C (HCV) infection is a major source of morbidity and mortality among HIV-infected patients. Despite decreasing HCV incidence in the United States, the proportion of cases among men who have sex with … Continue reading Article | Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010). Journal of Sexually Transmitted Diseases, 2015

NYS Department of Health Defines HCV Experienced Provider

Source: Defining the Experienced Hepatitis C Provider, New York State Department of Health AIDS Institute, June 2015 Transformative new treatments for hepatitis C virus (HCV) will greatly expand the number of patients in New York State who can be treated successfully. This expansion promises to reduce morbidity, mortality, and the incidence of HCV transmission, but it … Continue reading NYS Department of Health Defines HCV Experienced Provider

2015 National Summit on HCV & HIV Diagnosis, Prevention & Access to Care: Abstracts, Presentations & Posters

    Abstracts, Presentations, and Posters are now Available Online Abstracts, presentations, and posters from the 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care are available on the Summit webpage. Final Program and Abstract Book (PDF) Program Overview and Plenary Presentations Breakout Session Presentations Posters More information on the 2015 National Summit is available at http://www.hivforum.org/2015Summit … Continue reading 2015 National Summit on HCV & HIV Diagnosis, Prevention & Access to Care: Abstracts, Presentations & Posters

Report on Medicaid & Hep C Treatment Access (Center for Health Law & Policy Innovation)

 Medicaid and Hepatitis C Treatment Access. The Center for Health Law and Policy Innovation (CHLPI) at Harvard Law School recently released a report that analyzes hepatitis C treatment access in Medicaid fee-for-service and managed care programs in 10 states (including NYC). It also provides information about how advocates can use the report to advocate for … Continue reading Report on Medicaid & Hep C Treatment Access (Center for Health Law & Policy Innovation)

Article | Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013. Drug Alcohol Depend, 2015.

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug Alcohol Depend, 2015.  HCV prevalence among PWID (N:1535) was 67% during the study period, and was not significantly different from that observed in 2000-2001. The estimated HCV incidence among new injectors (persons injecting for ≤6 years) … Continue reading Article | Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013. Drug Alcohol Depend, 2015.

Article | A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support

Beyond Viral Response: a prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support.  International Journal of Drug Policy, 2015.  Highlights We prospectively study a community-based hepatitis C (HCV) treatment program serving active drug users in Toronto, Canada. We examine HCV care outcomes and changes in psycho-social status, including social determinants of health … Continue reading Article | A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support

Provider Reporting | How to Report Diseases, Events & Conditions to the NYC Health Dept

Provider Reporting: How to Report Diseases, Events, and Conditions to the New York City Health Department. The Guide provides a Table of all reportable diseases, and events including instructions on how and when they should be reported. The Guide is currently available on-line at http://www.nyc.gov/html/doh/downloads/pdf/hcp/reporting-guide.pdf. Please share with your colleagues and email Molly Kratz (mkratz@health.nyc.gov) … Continue reading Provider Reporting | How to Report Diseases, Events & Conditions to the NYC Health Dept

Article | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs

An international perspective on using opioid substitution treatment (OST) to improve hepatitis C prevention and care for people who inject drugs: structural barriers and public health potential. International Journal of Drug Policy, 2015.  Highlights  We examined the use of mediation assisted treatment of opioid dependence to improve the HCV control. The stigmatization of drug use is … Continue reading Article | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs

2014 Annual Report – Hep C (Treatment Action Group)

Treatment Action Group (TAG) is an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS. Read TAG’s 2014 Annual Report for program updates and news, including their HIV/Hepatitis Project update and plan: TAG’s Hepatitis/HIV Project draws from the core values and history of AIDS activism to end hepatitis C. … Continue reading 2014 Annual Report – Hep C (Treatment Action Group)

Hep C Testing Coverage Guide (The AIDS Institute)

In an effort to assist patients, clinics, and providers in obtaining coverage for HCV testing, The AIDS Institute is releasing an updated Coverage Guide for Hepatitis C Screening. The guide explains coverage of preventive services under the ACA and sets out specific coverage for HCV testing under various types of insurance, including private health plans, … Continue reading Hep C Testing Coverage Guide (The AIDS Institute)

Article | Study Shows Improved Socio-economic Outcomes After Community-based HCV Treatment Program

A new study demonstrates that a multi-disciplinary, community-based model of HCV treatment improves participant’s lives in ways that extend beyond Hepatitis C. Researchers from the University of Toronto worked with the Toronto Community Hep C Program to examine HCV care outcomes and changes in psycho-social-economic status, including social determinants of health and measures of well-being. … Continue reading Article | Study Shows Improved Socio-economic Outcomes After Community-based HCV Treatment Program

CDC | Outbreak of HIV/HCV in Prescription Med Injectors (Indiana)

This is an official CDC HEALTH ADVISORY Distributed via the CDC Health Alert Network April 24, 2015, 11:00 ET (11:00 AM ET) CDCHAN-00377 Summary The Indiana State Department of Health (ISDH) and the Centers for Disease Control and Prevention (CDC) are investigating a large outbreak of recent human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). … Continue reading CDC | Outbreak of HIV/HCV in Prescription Med Injectors (Indiana)

World Health Organization Issues 1st Hep B Treatment Guidelines

The World Health Organization (WHO) issued its first-ever guidance for the treatment of chronic hepatitis B. Worldwide, some 240 million people have chronic hepatitis B virus with the highest rates of infection in Africa and Asia. People with chronic hepatitis B infection are at increased risk of dying from cirrhosis and liver cancer. Key recommendations include: … Continue reading World Health Organization Issues 1st Hep B Treatment Guidelines

2014 NYC HEP Health Care Access Training Report

2014 NYC HEP Health Care Access Training Report View full meeting report here Agenda & Handout:_2014 NYC Hep Health Care Access Training (PDF) Presentations Nirah Johnson, NYC DOHMH, Viral Hepatitis Health Care Access Resources (PDF slides) An overview of the state of hep B and C in NYC, NYS laws regarding hep B and C, free printed education materials from NYC DOHMH (call … Continue reading 2014 NYC HEP Health Care Access Training Report

Article | TB & Viral Hepatitis, New York City, 2000–2010

 Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010. Epidemiol Infect. 2014 Nov. Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, Fuld J. Abstract SUMMARY Literature surrounding the burden of and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in … Continue reading Article | TB & Viral Hepatitis, New York City, 2000–2010

Article | Duplicate Hep C Antibody Testing in NYC (NYC Health Dept)

An evaluation of duplicate Hep C antibody testing conducted by NYC Department of Health staff has been published in the latest issue of Public Health Reports, Volume 129, Number 6, November/December 2014. ABSTRACT Repeating a hepatitis C virus antibody test for a person who previously tested positive provides no new information, wastes resources, and may reflect poor … Continue reading Article | Duplicate Hep C Antibody Testing in NYC (NYC Health Dept)

Medicare Guidelines | HCV screening for baby boomer & at risk beneficiaries

Overview: CMS has finalized its decision to reimburse for HCV screening in primary care settings, for individuals who are Medicare eligible and either “high risk” or born between 1945-1965. “High risk” is defined as persons with a current or past history of illicit injection drug use; and persons who have a history of receiving a blood transfusion … Continue reading Medicare Guidelines | HCV screening for baby boomer & at risk beneficiaries

New! Hep C CHI: NYC Health Dept Publication for Medical Providers

New! NYC Department of Health City Health Information (CHI) on Hep C 2014   The Diagnosing and Managing Hepatitis C CHI provides a thorough summary of risk assessment, testing recommendations, laboratory tests, and managing current HCV infection. There is specific information on how providers should speak to patients currently infected with HCV, as well as tables detailing common HCV … Continue reading New! Hep C CHI: NYC Health Dept Publication for Medical Providers

USPSTF Recommends Hep B Screening in High Risk Individuals

The U.S. Preventative Services Task Force has updated their 2004 recommendation on hepatitis B screening and now recommends screening for hepatitis B virus (HBV) in non-pregnant adolescents and adults at high risk for infection, which may include: Those born in countries where the prevalence of HBV infection is 2% or greater Those born in the … Continue reading USPSTF Recommends Hep B Screening in High Risk Individuals

AIDS Institute Releases Hep C Testing Coverage Guide

In recognition of Hepatitis Testing Day, May 19, The AIDS Institute has released a Hepatitis C (HCV) Testing Coverage Guide to assist health care providers with navigating each of the major healthcare payers’ coverage options for preventive services, specifically for HCV screening. Additionally, the guide will help educate people on the need to get tested … Continue reading AIDS Institute Releases Hep C Testing Coverage Guide

NYS COH Sends Dear Colleague Letter on Hep C Testing Law

Nirav R. Shah, M.D., the Commissioner of the New York State Health Department has released a Dear Colleague letter announcing the new Hepatitis C Testing Law.  (Section 2171) The new law, which will take effect January 1st, 2014, mandates that every individual born between 1945 and 1965 be offered a Hepatitis C screening in either … Continue reading NYS COH Sends Dear Colleague Letter on Hep C Testing Law

HHS Releases Action Plan for the Prevention, Care & Treatment of Viral Hepatitis Progress Report

Interagency Implementation Progress Report: HHS Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. Dear Colleagues – I am very pleased to share a new report that features 2012 highlights of federal efforts to implement the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis.  Released in May 2011, the Action Plan details goals, strategies, … Continue reading HHS Releases Action Plan for the Prevention, Care & Treatment of Viral Hepatitis Progress Report

Hep C in African Americans: Findings & Recommendations. National Medical Association Peer Reviewed Consensus Paper

From PRN Press Release: November 5th 2013. The National Medical Association (NMA) released the much anticipated Consensus Panel Paper entitled: Hepatitis C: A Crisis in the African American Community. The NMA is the nation’s largest and oldest association of African American physicians and when faced with the startling facts on the burden of Hepatitis C … Continue reading Hep C in African Americans: Findings & Recommendations. National Medical Association Peer Reviewed Consensus Paper

Article | Causes of Death among People with Hepatitis C in NYC, 2000‐2011

Causes of Death among People with Hepatitis C in NYC, 2000‐2011. Jessie Pinchoff, PhD Candidate, MPH, Ann Drobnik, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Sarah L. Braunstein PhD, Jay K. Varma, MD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC DOHMH) Poster: ID Week 2013 Conference Click … Continue reading Article | Causes of Death among People with Hepatitis C in NYC, 2000‐2011

Article | HIV/Hep C among Men who have Sex with Men in NYC, 2000‐2010 (NYC Health Dept)

HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC … Continue reading Article | HIV/Hep C among Men who have Sex with Men in NYC, 2000‐2010 (NYC Health Dept)

NYC Health Department Announces Strategic Plan to Combat Hepatitis C

TOP NEWS Health Department Announces Plan to Combat Hepatitis C The NYC Health Department today released the City’s first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS. In Hepatitis C in New York City: State of the Epidemic and Action … Continue reading NYC Health Department Announces Strategic Plan to Combat Hepatitis C

Hep C Screening: NYC Commissioner of Health Dear Colleague Letter (April 2013)

View as PDF: Dear Colleague COH-Hep C Screening 2013 April 2013 Dear Colleague: I am writing to ask your help with diagnosing and treating hepatitis C, an increasing cause of illness and death among New Yorkers. Across the nation, hepatitis C virus (HCV) now causes more deaths annually than HIV infection[1]. Because new drug regimens … Continue reading Hep C Screening: NYC Commissioner of Health Dear Colleague Letter (April 2013)

Harm Reduction Communication – Issue 17 – Fall 2012

This special double-issue of Harm Reduction Communication has two central themes: hepatitis C (HCV) and personal narrative.. There are articles on: taking HCV prevention to a new level beyond syringe-only messaging, HCV counseling, testing and referral, HCV treatment stories, group HCV treatment models, HCV advocacy, HCV and domestic violence, remembering Michael Carden, impersonality and drug … Continue reading Harm Reduction Communication – Issue 17 – Fall 2012

Pin It on Pinterest